Cercar

Barra de cerca
26/01/2022 The impact of improving haemophilia A management within the Spanish National Healthcare System: a social return on investment analysis
Soto, I, Mateo, J, Garcia-Diego, DA, Gil, B, Ruiz-Beato, E, Ivanova, Y, Lorenzo, TM, Maravilla-Herrera, P, Hidalgo-Vega, A, Merino, M. The impact of improving haemophilia A management within the Spanish National Healthcare System: a social return on investment analysis. BMC HEALTH SERVICES RESEARCH. 2022; 22(1)DOI:10.1186/s12913-021-07447-4. PMID:35081958. IF:2.800(Q3/6D).
21/01/2022 Current status of diagnosis and treatment of heparin-induced thrombocytopenia (HIT)
Paramo, JA, Lozano, ML, Gonzaalez-Porras, JR, Mateo, J. Current status of diagnosis and treatment of heparin-induced thrombocytopenia (HIT). MEDICINA CLINICA. 2022; 158(2)DOI:10.1016/j.medcli.2021.05.020. PMID:34311973. IF:3.900(Q2/4D).
01/01/2022 Impact of increased kidney function on clinical and biological outcomes in real-world patients treated with Direct Oral Anticoagulants
Corrochano M., Acosta-Isaac R., Plaza M., Muñoz R., Mojal S., Moret C., Souto J.C.. Impact of increased kidney function on clinical and biological outcomes in real-world patients treated with Direct Oral Anticoagulants. PLoS One. 2022; 17(12)DOI:10.1371/journal.pone.0278693. PMID:36490245. IF:3.700(Q2/4D).
01/11/2021 Type 2N VWD: Conclusions from the Spanish PCM-EVW-ES project
Perez-Rodriguez, A, Batlle, J, Pinto, JC, Corrales, I, Borras, N, Garcia-Martinez, I, Cid, AR, Bonanad, S, Parra, R, Mingot-Castellano, ME, Navarro, N, Altisent, C, Perez-Montes, R, Moreto, A, Herrero, S, Soto, I, Mosteirin, NF, Jimenez-Yuste, V, Jacob, AD, Fontanes, E, Mateo, J, Quismondo, NC, Batlle, F, Vidal, F, Lopez-Fernandez, MF. Type 2N VWD: Conclusions from the Spanish PCM-EVW-ES project. HAEMOPHILIA. 2021; 27(6)DOI:10.1111/hae.14405. PMID:34494337. IF:4.268(Q2/5D).
12/10/2021 Management of acquired hemophilia A: results from the Spanish registry
Mingot-Castellano, ME, Pardos-Gea, J, Haya, S, Bastida-Bermejo, JM, Tassies, D, Marco-Rico, A, Nunez, R, Garcia-Candel, F, De Mora, MCFS, Soto, I, Alvarez-Roman, MT, Asenjo, S, Carrasco, M, Lluch-Garcia, R, Martin-Antoran, JM, Rodriguez-Alen, A, Rosello, E, Torres-Minana, L, Marcellini-Antonio, S, Moreto-Quinana, A, Rodriguez-Garcia, JA, Aguinaco-Culebras, R, Alonso-Escobar, N, Cervero-Santiago, C, Fernandez-Mosteirin, N, Martinez-Badas, MP, Perez-Sanchez, M, Perez-Montes, R, Rodriguez-Gonzalez, R, Uribe-Barrientos, M, Caparros-Miranda, IS, Iglesias-Fernandez, M, Baena, A, Rodriguez-Lopez, M, Sebrango-Sandia, A, Vazquez-Fernandez, I, Marco, P. Management of acquired hemophilia A: results from the Spanish registry. Blood Advances. 2021; 5(19)DOI:10.1182/bloodadvances.2021004626. PMID:34521101. IF:7.642(Q1/3D).
02/09/2021 Expert opinion paper on the treatment of hemophilia B with albutrepenonacog alfa
Roman, MTA, Benitez, O, Canaro, MI, Fernandez, MFL, Jaime, FLJ, Arranz, JM, Nunez, R, Lopez, MR, Aisa, CS, Jimenez-Yuste, V. Expert opinion paper on the treatment of hemophilia B with albutrepenonacog alfa. EXPERT OPINION ON BIOLOGICAL THERAPY. 2021; 21(9)DOI:10.1080/14712598.2021.1932811. PMID:34225551. IF:5.589(Q1/3D).